eXTReMe Tracker
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter August 2010

Gene Therapy Net Banner
News: CliniGene Competitive Call for Additional Project Partners
Programme title: CliniGene, (Contract number LSHB-CT-2006-018933), the European Network of Excellence for the Advancement of Clinical Gene Transfer and Therapy.

CliniGene seeks additional partners to enter its Joint Programme Activity on the topics:
Topic 1. Non-viral integrating systems for clinical gene therapy and development of human iPS, in particular transposon based technology;
Topic 2. AAV for in vivo gene therapy, in particular mechanisms leading to tight transcription regulation;
Topic 3. Technology transfer to SMEs for: (i) systems which have benefited from common evaluation and fine-tuning inside the NoE; (ii) a technology that is believed to complement the CliniGene current portfolio with view to performing side to side comparisons with gene transfer technologies already evaluated within CliniGene.

General conditions:
One or at best two applicants only may be successful for Topic 1.
One applicant only may be successful for Topic 2.
Five applicants at most may be successful for Topic 3.
The applicant must seek integration within the CliniGene consortium through the establishment of a research and development project in common with partners, and a compulsory commitment to participate into the “Flexibility funds” internal programme. Sub-contracting of a service will not be eligible.
Evaluation will be performed according to the excellency of the proposed research. In addition, integration into the ongoing activities of the Network will be of paramount importance. When applying to Topic 3 involving SMEs, the evaluators will also consider the applicant’s potential for maximising the socio-economic impact.
Please refer to FP6-EC rules for the list of eligible countries that can participate and be funded besides EU-based entities: http://cordis.europa.eu/fp6/stepbystep/who.htm

Estimated EC- contribution to the funding of the tasks:
Topic 1: € 130.000,00
Topic 2: € 65.000,00
Topic 3: € 150.000,00

Participation in project: until September 2011 (with planned extension of the EC contract)

Deadline: The call closes at 17:00 (Brussels time) on August 30th 2010.

Call information: please find the call text, the topic descriptions and the application forms on http://www.clinigene.eu


Read more...

Conference: 3rd annual Workshop on Genome Engineering
The Northwest Genome Engineering Consortium (NGEC) in Seattle is pleased to announce the 3rd annual Workshop on Genome Engineering. The NGEC works to develop homing endonucleases for genome engineering applications, such as gene editing of various types of hematopoietic and lymphoid cells, and stem cells. This one-day workshop will take place on Tuesday, November 16th, 2010 in Seattle and is designed to provide a forum for exposure to and discussion of genome engineering concepts, methods, and applications under study in both consortium and non-consortium laboratories.

The workshop features two Keynote addresses by Dr. Toni Cathomen (Hannover Medical School, Germany) and Dr. Bruce Torbett (Scripps Research Institute, La Jolla, CA) as well as research presentations and a poster session. Registration is free and open to everyone; travel scholarships are available. More information as well as the registration and travel scholarship documentation is available on our website at http://sites.google.com/site/ngecseattle/.

Feel free to forward this information to anyone you think might be interested. For questions and comments, contact the NGEC Project Coordinator Andre Durudas at This email address is being protected from spambots. You need JavaScript enabled to view it..


Read more...


Conferences
- 26 August - 4 September 2010, Viral Vectors in Gene Therapy: Applications and Novel Production Methods, A.I. Virtanen Institute, Kuopio, Finland
- 24 - 27 September 2010, Cellular Therapy of Cancer Symposium - ATTACK Project Meeting, Montpellier, France
- 6 - 9 October 2010, 17th Annual Meeting German Society for Gene Therapy (DG-GT e.V.), Munich, LMU Campus Grosshadern, Germany
- 7 October 2010, COGEM Symposium: GM viruses as medicine: panacea or pandora's box?, Amsterdam, The Netherlands
- 22 - 25 October 2010, European Society of Gene and Cell Therapy (ESGCT) 18th Annual Congress, Milan, Italy
- 16 November 2010, 3rd annual Workshop on Genome Engineering, Seattle, WA
- 17 - 19 November 2010, 9th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases. Focus Topic: Gene Expression, Sonoma, CA
- 24 - 26 January 2011, Phacilitate 7th Annual Cell & Gene Therapy Forum 2011, Washington DC, MD
- 10 - 11 March 2011, Spring Meeting of the Dutch Society of Gene Therapy (NVGT), Heeze, The Netherlands
- 16 - 19 March 2011, 6th International Conference on Oncolytic Viruses as Cancer Therapeutics, Las Vegas, NV
- 4 - 6 May 2011, Australasian Gene Therapy Society (AGTS) 7th Meeting, Melbourne, Australia
- 18 - 22 May 2011, American Society of Gene and Cell Therapy (ASGCT) 14th Annual Meeting, Seattle, WA
- 29 May - 2 June 2011, Gordon Research Conference: Virusses & Cells, Lucca (Barga), Italy
- 15 – 17 July 2011, The 17th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Kyushu University, Fukuoka, Japan
- 27 - 31 October 2011, British Society of Gene Therapy (BSGT) 8th Annual Conference, Brighton, UK

Read more...

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines, www.genetherapynet.com
To unsubscribe from the Newsletter, please login and edit your subscription details or contact us